Dr. Rao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S 31st St
Temple, TX 76508Phone+1 254-724-2111
Education & Training
- Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Pathology-Anatomic and Clinical, 1992 - 1996
- Mysore Medical CollegeClass of 1982
Certifications & Licensure
- TX State Medical License 1996 - 2026
- IA State Medical License 1994 - 2012
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Clinical Trials
- A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel Start of enrollment: 2015 Jan 01
- A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- 190 citationsImmuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.Ik Sun Kim, Yang Gao, Thomas Welte, Hai Wang, Jun O. Liu
Nature Cell Biology. 2019-08-26 - 38 citationsExpression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.Ann-Margaret Ochs, Lucas Wong, Vijaya Kakani, Srilatha Neerukonda, Julie Gorske
Clinical Colorectal Cancer. 2004-11-01 - 9 citationsTrichomonas vaginalis Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG Test.Barbara Van Der Pol, Arundhati Rao, Melinda B. Nye, Steven E. Chavoustie, Aaron Ermel
Journal of Clinical Microbiology. 2021-09-20
Journal Articles
- Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract SpecimensArundhati Rao, MD, mBio
Press Mentions
- Biomarker Predicts Poor Prognosis in African-Americans with Triple-Negative Breast Cancer, Study FindsFebruary 20th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: